🕵️ Spruce Biosciences, Inc. ($SPRB)
SEC insider & ownership activity, last 12 months · CIK 1683553 · every row links its SEC filing
Over the last 12 months insiders sold $10K against $9K of open-market buying. Parkman Healthcare Partners LLC sold $10K (Oct). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
1 buyer, $9K (2 lots) · 1 seller, $10K (4 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Parkman Healthcare Partners LLC | 2 | $9K | 4 | $10K | Oct 6, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Integrated CORE Strategies (US) LLC | 9.6% | 13G | Feb 24, 2026 | filing ↗ | |
| Millennium Management LLC | 9.6% | 13G | Feb 24, 2026 | filing ↗ | |
| Millennium Group Management LLC | 9.6% | 13G | Feb 24, 2026 | filing ↗ | |
| Israel A. Englander | 9.6% | 13G | Feb 24, 2026 | filing ↗ | |
| Orin Hirschman | 9.1% | 13G | Jul 27, 2026 | filing ↗ | |
| AIGH Capital Management LLC | 9.1% | 13G | Jul 27, 2026 | filing ↗ | |
| Boone Peter David Mr | 6.4% | 13G | Nov 24, 2025 | filing ↗ | |
| ADAR1 Capital Management, LLC | 5.4% | 13G | Feb 17, 2026 | filing ↗ | |
| Daniel Schneeberger | 5.4% | 13G | Feb 17, 2026 | filing ↗ | |
| Citadel Advisors LLC | 5.1% | 13G | May 15, 2026 | filing ↗ | |
| Citadel Advisors Holdings LP | 5.1% | 13G | May 15, 2026 | filing ↗ | |
| Citadel GP LLC | 5.1% | 13G | May 15, 2026 | filing ↗ | |
| Kenneth Griffin | 5.1% | 13G | May 15, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Officer/director changes (5.02) | Jul 27, 2026 | filing ↗ |
| Shareholder vote (5.07) | May 21, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 21, 2026 | filing ↗ |
| Earnings (2.02) | May 13, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 13, 2026 | filing ↗ |
| Material agreement (1.01) | Apr 20, 2026 | filing ↗ |
| Other events (8.01) | Apr 20, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 20, 2026 | filing ↗ |
| Agreement terminated (1.02) | Mar 16, 2026 | filing ↗ |
| Material agreement (1.01) | Mar 9, 2026 | filing ↗ |
| Agreement terminated (1.02) | Mar 9, 2026 | filing ↗ |
| Earnings (2.02) | Mar 9, 2026 | filing ↗ |
| Officer/director changes (5.02) | Mar 9, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 9, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Feb 5, 2026 | filing ↗ |
| Other events (8.01) | Feb 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 5, 2026 | filing ↗ |
| Material agreement (1.01) | Jan 7, 2026 | filing ↗ |
| Earnings (2.02) | Jan 7, 2026 | filing ↗ |
| New financial obligation (2.03) | Jan 7, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Jan 7, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 7, 2026 | filing ↗ |
| Officer/director changes (5.02) | Dec 11, 2025 | filing ↗ |
| Officer/director changes (5.02) | Dec 11, 2025 | filing ↗ |
| Earnings (2.02) | Nov 10, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 10, 2025 | filing ↗ |
| Officer/director changes (5.02) | Oct 15, 2025 | filing ↗ |
| Material agreement (1.01) | Oct 7, 2025 | filing ↗ |
| Unregistered equity sale (3.02) | Oct 7, 2025 | filing ↗ |